In a notable shift in investment sentiment, Replimune Group, Inc. (NASDAQ: REPL) received a “Hold” rating from Roger Song of Jefferies on April 13, 2026. With the stock currently priced at $4.76, the analyst has set a price target of $2, suggesting potential downside if the market does not respond positively to the company’s future performance metrics. For investors, this rating may signify a critical juncture for assessing Replimune’s viability within a volatile sector.
Recent Price Action
The recent trading behavior of REPL reflects a turbulent market landscape. Over the past week, the stock has shown significant volatility, with recent price fluctuations resulting in a decline of nearly 63% to its current value of $4.76. The stock has traded as low as $186.94 over its 52-week range, underscoring the severity of the correction experienced in recent sessions. With a beta of 0.744, REPL has displayed lower volatility compared to the broader market, yet the vast trading volume of over 48 million shares signals heightened investor interest and potential panic selling. As the stock grapples with this dramatic drop, maintaining an average volume of 1.5 million shares in more stable times hints at prior investor confidence that may now be wavering.
Historical Performance
Analyzing REPL’s performance over different time frames reveals a mixed picture. The stock has experienced substantial depreciation, down 27.43% over the past month and 32.34% year-over-year. However, in stark contrast, it saw a remarkable rebound of 55.78% over the previous quarter. This juxtaposition highlights the stock’s hefty volatility and suggests that, while the stock may attract opportunistic traders, long-term investors could be reevaluating their positions as they navigate significant market swings. Recent weekly volatility sits at 7.04%, further emphasizing the unpredictable nature of REPL’s market behavior.
Earnings Analysis
In its latest earnings report released on November 6, 2025, Replimune posted an earnings per share (EPS) of -$0.90, slightly below the estimated -$0.87. This minor miss represents a 3.45% negative surprise, in stark contrast to the previous quarter’s EPS of -$0.95, which had a more significant surprise factor of 14.46% against an estimate of -$0.83. This mixed performance hints at a pattern of uncertainty that could be influencing the company’s stock price and market perception. The ability to consistently meet or exceed earnings estimates will be crucial for Replimune as it seeks to regain investor confidence and demonstrate its operational stability.
Analyst / Consensus View
The consensus view among analysts reflects a cautious approach towards Replimune, especially after the recent downgrade to a “Hold.” The stock currently enjoys a total of five ratings, split between two “Buy,” three “Hold,” and no “Sell” recommendations. The average price target stands at an optimistic $7.80, with a high target of $19 and a low of $2. This disparity among expectations suggests that while some analysts see potential upside, others remain apprehensive about the stock’s near-term performance, especially given its recent trends.
Stock Grading or Fundamental View
Replimune holds a Stocks Telegraph Grade of 35, a reflection of its current performance metrics and overall investment health. This score suggests that the company faces challenges ahead, evidenced by its volatile stock price and mixed financial performance. While a grade of 35 may point toward potential for recovery, it indicates that fundamental strengths need bolstering to facilitate sustained interest from investors.
Conclusion
For investors contemplating entry into Replimune Group, Inc. (REPL), the current “Hold” rating may serve as a warning sign to approach with caution. The stock appears more suited for traders seeking short-term opportunities rather than long-term holds. While there exists notable upside potential, particularly for risk-tolerant investors, the recent turmoil and lack of consistent earnings performance indicate that substantial risks linger. This stock warrants careful observation as market conditions evolve and the company seeks to stabilize its operations amidst the backdrop of investor uncertainty.